rs17161018
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_000840.3(GRM3):c.1325-23224G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0768 in 151,774 control chromosomes in the GnomAD database, including 634 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.077 ( 634 hom., cov: 32)
Consequence
GRM3
NM_000840.3 intron
NM_000840.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.17
Publications
1 publications found
Genes affected
GRM3 (HGNC:4595): (glutamate metabotropic receptor 3) L-glutamate is the major excitatory neurotransmitter in the central nervous system and activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors, that have been divided into 3 groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5 and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3 while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.118 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRM3 | NM_000840.3 | c.1325-23224G>A | intron_variant | Intron 3 of 5 | ENST00000361669.7 | NP_000831.2 | ||
GRM3 | NM_001363522.2 | c.1324+28499G>A | intron_variant | Intron 3 of 4 | NP_001350451.1 | |||
GRM3 | XM_047420268.1 | c.1325-23224G>A | intron_variant | Intron 4 of 6 | XP_047276224.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0769 AC: 11658AN: 151656Hom.: 634 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
11658
AN:
151656
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.0768 AC: 11658AN: 151774Hom.: 634 Cov.: 32 AF XY: 0.0735 AC XY: 5449AN XY: 74184 show subpopulations
GnomAD4 genome
AF:
AC:
11658
AN:
151774
Hom.:
Cov.:
32
AF XY:
AC XY:
5449
AN XY:
74184
show subpopulations
African (AFR)
AF:
AC:
900
AN:
41452
American (AMR)
AF:
AC:
1225
AN:
15202
Ashkenazi Jewish (ASJ)
AF:
AC:
307
AN:
3456
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
104
AN:
4816
European-Finnish (FIN)
AF:
AC:
643
AN:
10562
Middle Eastern (MID)
AF:
AC:
32
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8122
AN:
67796
Other (OTH)
AF:
AC:
209
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
542
1085
1627
2170
2712
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
49
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.